Bank Of America Corp Profound Medical Corp. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Profound Medical Corp. stock. As of the latest transaction made, Bank Of America Corp holds 203,090 shares of PROF stock, worth $1.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

203,090

Previous 203,290 0.1%

Holding current value

$1.53 Million

Previous $1.71 Million 5.22%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.47 - $11.18 $1,494 - $2,236	-200 Reduced 0.1%	203,090 $1.62 Million
Q2 2024 Aug 14, 2024	SELL	$7.25 - $9.07 $5,075 - $6,349	-700 Reduced 0.34%	203,290 $1.71 Million
Q1 2024 May 15, 2024	SELL	$7.3 - $9.46 $31,046 - $40,233	-4,253 Reduced 2.04%	203,990 $1.74 Million
Q4 2023 Feb 14, 2024	BUY	$7.85 - $11.18 $234,722 - $334,293	29,901 Added 16.77%	208,243 $1.77 Million
Q2 2023 Aug 14, 2023	BUY	$9.27 - $14.88 $7,434 - $11,933	802 Added 0.45%	178,342 $2.32 Million
Q1 2023 May 12, 2023	SELL	$8.85 - $13.27 $16,222 - $24,323	-1,833 Reduced 1.02%	177,540 $1.65 Million
Q4 2022 Feb 10, 2023	BUY	$3.18 - $10.91 $11,998 - $41,163	3,773 Added 2.15%	179,373 $1.95 Million
Q3 2022 Nov 14, 2022	BUY	$3.99 - $9.3 $391,419 - $912,330	98,100 Added 126.58%	175,600 $710,000
Q2 2022 Aug 12, 2022	SELL	$6.34 - $9.53 $5,566 - $8,367	-878 Reduced 1.12%	77,500 $564,000
Q1 2022 May 16, 2022	BUY	$8.16 - $11.33 $26,046 - $36,165	3,192 Added 4.25%	78,378 $706,000
Q4 2021 Feb 08, 2022	SELL	$10.38 - $15.2 $124,995 - $183,038	-12,042 Reduced 13.81%	75,186 $844,000
Q3 2021 Nov 15, 2021	BUY	$13.6 - $17.88 $503,771 - $662,310	37,042 Added 73.81%	87,228 $1.28 Million
Q2 2021 Sep 13, 2021	BUY	$16.0 - $20.59 $802,976 - $1.03 Million	50,186 New	50,186 $821,000

Others Institutions Holding PROF

# of Institutions

Shares Held

8.93M

Call Options Held

1.2K

Put Options Held

View Full List

About Profound Medical Corp.

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $157M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

More about PROF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Profound Medical Corp. Transaction History